These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28726109)

  • 1. The study of immunogenicity of the antigenic protein of high risk oncogenic type of the human papillomavirus HPV16 L1 produced in the plant expression system on the base of transgenic tomato.
    Salyaev RK; Rekoslavskaya NI; Stolbikov AS; Tretyakova AV
    Dokl Biochem Biophys; 2017 May; 474(1):186-188. PubMed ID: 28726109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the omega leader sequence of tobacco mosaic virus to transform tomato fruits with the papillomavirus hpv16 L1 gene to enhance production of the antigenic protein HPV16 L11.
    Salyaev RK; Rekoslavskaya NI; Stolbikov AS; Tret'yakova AV
    Dokl Biochem Biophys; 2016 May; 468(1):187-9. PubMed ID: 27417716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice.
    Paz De la Rosa G; Monroy-García A; Mora-García Mde L; Peña CG; Hernández-Montes J; Weiss-Steider B; Gómez-Lim MA
    Virol J; 2009 Jan; 6():2. PubMed ID: 19126233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1.
    Cho HJ; Shin HJ; Han IK; Jung WW; Kim YB; Sul D; Oh YK
    Vaccine; 2007 Nov; 25(47):8049-57. PubMed ID: 17936447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
    Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
    Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Synthesis of Main Capsid Protein of Anogenital Type HPV6 L1 in Plant Expression System on the Basis of Tomato Fruits.
    Rekoslavskaya NI; Salyaev RK; Stolbikov AS
    Dokl Biochem Biophys; 2021 May; 498(1):193-198. PubMed ID: 34189649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Production of human papillomavirus type 16 virus-like particles and its immunogenicity].
    Wei MX; Li SW; Huang B; Shen WT; Su YZ; Zhang CH; Gu Y; Du HL; Zhang J; Xia NS
    Bing Du Xue Bao; 2009 Jul; 25(4):245-50. PubMed ID: 19769155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of HPV 16 L1/E7 DNA immunization: influence of cellular localization and capsid assembly.
    Kuck D; Leder C; Kern A; Müller M; Piuko K; Gissmann L; Kleinschmidt JA
    Vaccine; 2006 Apr; 24(15):2952-65. PubMed ID: 16414157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice.
    Hongli L; Xukui L; Ting L; Wensheng L; Lusheng S; Jin Z
    Hum Vaccin Immunother; 2013 Jan; 9(1):83-9. PubMed ID: 23108357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants.
    Liu HL; Li WS; Lei T; Zheng J; Zhang Z; Yan XF; Wang ZZ; Wang YL; Si LS
    Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):153-8. PubMed ID: 15756416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV16 L1 diversity and its potential impact on the vaccination-induced immunity.
    El Aliani A; El Abid H; Kassal Y; Khyatti M; Attaleb M; Ennaji MM; El Mzibri M
    Gene; 2020 Jul; 747():144682. PubMed ID: 32304786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy.
    Fleury MJ; Touzé A; Coursaget P
    Mol Biotechnol; 2014 May; 56(5):479-86. PubMed ID: 24639327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective immune response of guinea pigs against challenge with foot and mouth disease virus by immunization with foliar extracts from transgenic tomato plants expressing the FMDV structural protein VP1].
    Pan L; Zhang YG; Wang YL; Wang BQ; Xie QG
    Wei Sheng Wu Xue Bao; 2006 Oct; 46(5):796-801. PubMed ID: 17172031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine.
    Gu Y; Wei M; Wang D; Li Z; Xie M; Pan H; Wu T; Zhang J; Li S; Xia N
    Vaccine; 2017 Aug; 35(35 Pt B):4637-4645. PubMed ID: 28736197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaques.
    Nieto K; Stahl-Hennig C; Leuchs B; Müller M; Gissmann L; Kleinschmidt JA
    Hum Gene Ther; 2012 Jul; 23(7):733-41. PubMed ID: 22401308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors.
    Nieto K; Kern A; Leuchs B; Gissmann L; Müller M; Kleinschmidt JA
    Antivir Ther; 2009; 14(8):1125-37. PubMed ID: 20032542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer.
    Echchannaoui H; Bianchi M; Baud D; Bobst M; Stehle JC; Nardelli-Haefliger D
    Infect Immun; 2008 May; 76(5):1940-51. PubMed ID: 18332214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1.
    Baud D; Ponci F; Bobst M; De Grandi P; Nardelli-Haefliger D
    J Virol; 2004 Dec; 78(23):12901-9. PubMed ID: 15542642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11.
    Slupetzky K; Gambhira R; Culp TD; Shafti-Keramat S; Schellenbacher C; Christensen ND; Roden RB; Kirnbauer R
    Vaccine; 2007 Mar; 25(11):2001-10. PubMed ID: 17239496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.